CNN logo
navigation

Search


Pathfinder
Health half banner advertisement
rule

In other news...

August 27, 1996
Web posted at: 9:30 p.m. EDT

Advisory panel to rule on stimulant ephedra

drug

WASHINGTON (CNN) -- An FDA advisory panel is to announce Wednesday whether any level of the stimulant ephedra, the botanical version of the drug ephedrine, is safe to consume.

The federal Food and Drug Administration has received more than 800 reports of adverse effects and 17 deaths linked to more than 100 products that contain ephedra, also called ma huang or epitonin.

Manufacturers contend any problems can be solved with better labeling of their products, which are used for body-building, weight loss and energy boosting. The products now carry little information about the widely varying amounts of ephedra they contain.

Reporter Kathleen Koch contributed to this report.

Related site:

rule
What You Think Tell us what you think!

You said it...
advertisement
rule

To the top

© 1996 Cable News Network, Inc.
All Rights Reserved.

Terms under which this service is provided to you.